New for ASM Microbe 2020 | Emerging Science Abstracts!

Make an impact at ASM Microbe 2020 by presenting your novel, unanticipated, high impact or disruptive research during an Emerging Science Slide Session in the Lounge and Learn.  These sessions are a great opportunity to share your new findings that have a clear public impact, are related to a new outbreak (such as the novel coronavirus), or describes a newly uncovered biological mechanism. 

Accepted abstracts will give an oral presentation in a Lounge and Learn slide session, but will not present a poster in the Exhibit and Poster Hall. Instead, each presenter will have up to 5 minutes to share a three-slide presentation on his or her research and take questions from the audience. 

The limited emerging science abstract submission window opens on April 1, 2020 and closes on April 15, 2020 5pm EST. Dispositions will be sent on or around May 4, 2020.  


Please note: This is not an opportunity to submit an abstract that only describes a rigorous study that could have been submitted during the general submission period.

Lounge and Learn

Lounge and Learns are dedicated open space for each scientific track where you can relax and connect with peers during the meeting.  Watch live broadcasts of General or Cross track sessions, and participate in shorter, more interactive sessions with speakers. 

Register for Microbe 2020!

ASM Microbe 2020 will host thousands of poster and oral presentations where scientists will obtain valuable feedback on their research and gain new perspectives from leading experts.

Thank you to everyone who has submitted an abstract. Dispositions will be sent by the end of February.

Questions? Please contact asmmicrobemtgprogram@asmusa.org

Important Dates

End of February 2020
Microbe Dispositions Sent 

Mid-March 2020
Travel Award Dispositions Sent 

March 20, 2020
Abstract Withdrawal Deadline 

Early-April 2020 
Poster Presentations and Oral Presentation Assignments Sent 

What You Need Before Submitting Your Abstract

  1. Abstract Title: Please use a short and concise title that indicates the content of the abstract. (Note: the title is not included in the total character count of 2200). 
  2. Abstract Body Text: Your abstract may have up to 2200 characters, which does not include title, authors, groups, and affiliations. Tables and graphics (maximum of 500 characters) are included in the character count. Spaces are not counted. Do NOT include abstract title, authors or keywords in abstract text. Abstract text may be submitted using either of the following methods: Copy/paste, direct entry keystrokes, or file upload. Your abstract may be written without the use of the following bolded headers (Background, Methods, Results, Conclusion). However, follow the abstract guidelines to ensure all required information about your study is provided in your abstract. 
  3. Author(s) Information: Author(s)'s name(s), institution(s), location(s), title(s). 
  4. CE Disclosures: Relative to this activity, instructors, planners, content reviewers and managers who affect the content of a CME/CE activity are required to disclose relevant financial relationships they have with commercial interests (i.e., any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients).
  5. Travel Awards: When submitting your abstract, you can also simultaneously apply for one or more travel awards. Review the Travel Awards offered for ASM Microbe 2020. Be sure to have any needed supporting documents ready for uploading at the time of abstract submission (e.g. nomination letter). 

Abstract Guidelines

All Submitted Abstracts
  • It is preferred that ASM Microbe 2020 be the first major presentation of the abstract. 
  • A presenter may be a presenter on more than one abstract.
  • Programming decisions are considered final. 
  • Abstracts must be well written and easy to understand.
  • Approval of all co-authors must be obtained before placing their names on an abstract.
  • Submission of multiple overlapping abstracts is discouraged.
Clinical/Educational Tracks (AAR, CPHM, CIV, POM)
  • The reason for the study or how the study came about (e.g. hypothesis, discovery or central question) should be clearly stated.
  • Methods must be included.
  • Data must be objectively gathered, analyzed and reported.
  • Data must support the stated conclusion(s).
  • All presentations dealing with the isolation, purification, structure-activity relationships, mechanisms of action, in vivo/in vitro microbiology, PK/PD in animals and Pre-US IND or non-US early phase I studies must include meaningful data (e.g., producing organism, purification steps, physical-chemical characterization, structures, MICs, ED50s to describe new compounds and their properties, and that chemical structures of lead compounds will be included as part of the poster presentation. Please note: Any posters or talks dealing with a specific small molecule antimicrobial agent must provide a chemical structure, or a literature reference to the structure, in order to be presented at the meeting. Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track.
  • Scientific presentations at ASM Microbe 2020 will be expected to transparently report a study’s scientific rigor, including, but not limited to the following: 1) experimental design; 2) methodology; 3) data collection; 4) analysis; and 5) interpretation and report of results. Other key components of scientific rigor included, if applicable, are sample size, randomization, blinding, and replication.
Basic Science Tracks (AES, EEB, HMB, MBP)
  • The reason for the study or how the study came about (e.g. hypothesis, discovery or central question) should be clearly stated.
  • Data must be objectively gathered, analyzed and reported.
  • Data must support the stated conclusion(s).
  • Conclusion(s) should be made, but the study does not need to be fully complete (the standard to present at ASM Microbe is not the same as to publish in a journal). 
  • Abstracts describing biological data on an antimicrobial agent whose chemical structure has not been defined should be submitted to the HMB track. 
  • Scientific presentations at ASM Microbe 2020 will be expected to transparently report a study's scientific rigor, including, but not limited to the following: 1) experimental design; 2) interpretation and report of results.